A recent study has shown that FGF21 prevents diabetes-induced cardiac apoptosis by activating the ERK–p38MAPK–AMPK pathway (Figure 1); therefore, FGF21 has been proposed as a treatment for diabetes-related cardiac damage (32). The gene discussed is FGF21; the disease is diabetes mellitus.